Search Results

Agricola

Record details

Gene therapy with neprilysin reduces amyloid deposits in mice.

• Authors : Senior, Kathryn

Subjects: ALZHEIMER'S disease treatment; GENE therapy; ENZYMESUNITED States

• Source: Lancet. 3/29/2003, Vol. 361 Issue 9363, p1107. 1p. 1 Color Photograph.

Record details

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.

• Authors : Ruilope, Luis Miguel; Dukat, Andrej; Böhm, Michael

Subjects: REGULATION of blood pressure; VALSARTAN; ANGIOTENSINS

• Source: Lancet. 4/10/2010, Vol. 375 Issue 9722, p1255-1266. 12p. 1 Diagram, 4 Charts, 4 Graphs.

Record details

Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Abeta to physiologically relevant proteolytic degradation.

• Authors : Tsubuki, Satoshi (AUTHOR); Takaki, Yoshie (AUTHOR); Saido, Takaomi C (AUTHOR)

• Source: Lancet. 6/7/2003, Vol. 361 Issue 9373, p1957-1958. 2p.

Record details

Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation.

• Authors : Satoshi Tsubuki; Yoshie Takaki; Takaomi C Saido

Subjects: AMYLOIDOSIS; PROTEIN metabolism disorders; PEPTIDES

• Source: Lancet. 6/7/2003, Vol. 361 Issue 9373, p1957. 2p. 2 Graphs.

Record details

Proteolysis problems implicated in neurodegenerative diseases.

• Authors : Bradbury, Jane

Subjects: NEURODEGENERATION; PROTEOLYTIC enzymes; HUNTINGTON disease

• Source: Lancet. 05/26/2001, Vol. 357 Issue 9269, p1679. 3/5p. 1 Color Photograph.

Record details

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.

• Authors : Zannad, Faiez (AUTHOR); Ferreira, João Pedro (AUTHOR); Pocock, Stuart J (AUTHOR)

Subjects: DAPAGLIFLOZIN; EMPAGLIFLOZIN; BOEHRINGER Ingelheim Pharmaceuticals Inc.NEW York (State)

• Source: Lancet. 9/19/2020, Vol. 396 Issue 10254, p819-829. 11p.

Record details

Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials.

• Authors : Vaduganathan, Muthiah (AUTHOR); Claggett, Brian L (AUTHOR); Jhund, Pardeep S (AUTHOR)

Subjects: HEART failure patients; RANDOMIZED controlled trials; TREATMENT effectiveness

• Source: Lancet. 7/11/2020, Vol. 396 Issue 10244, p121-128. 8p.

Record details

Effect of angiotensin-converting-enzyme inhibitors.

• Authors : Deddish, Peter A (AUTHOR); Erdös, Ervin E (AUTHOR)

Subjects: ACE inhibitors; AZEPINES; CELL culture

• Source: Lancet. 9/21/2002, Vol. 360 Issue 9337, p947-947. 1p.

Record details

Heart failure.

• Authors : Metro, Marco; Teerlink, John R.; Metra, Marco (AUTHOR)

Subjects: HEART failure patients; CARDIOVASCULAR diseases; ANGIOTENSIN converting enzyme

• Source: Lancet. 10/28/2017, Vol. 390 Issue 10106, p1981-1995. 15p. 3 Diagrams, 2 Charts.

Record details